October 19, 2011
Novo Nordisk A/S filed suit Friday in New Jersey aiming to block Sandoz Inc.'s generic version of diabetes treatment Prandin, the latest broadside in an ongoing feud with generic-drug makers over a patent the U.S. Supreme Court has agreed to scrutinize later this year.